SCHEMBL6206587

SCHEMBL6206587

CCCC(=O)C(C(=O)O)=C(N)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 5/20 0.58
CES1 P23141 5/20 0.58
L3MBTL1 Q9Y468 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 3/20 0.41
RECQL P46063 2/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
PARP1 P09874 1/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ESR1 P03372 1/20 0.40
LMNA P02545 1/20 0.40
PTPN1 P18031 1/20 0.39
ERCC5 P28715 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6206992 0.86 CES1 (0.55) CES2CES1L3MBTL1SMN1; SMN2HPGD
SCHEMBL433480 0.79 MAPT (0.56) CES2CES1L3MBTL1SMN1; SMN2HPGD
SCHEMBL6206584 0.76 CES2 (0.58) CES2CES1L3MBTL1SMN1; SMN2HPGD
SCHEMBL16942397 0.75 MEN1 (0.60) SMN1; SMN2MAPTTSHRHSD17B10TDP1
SCHEMBL15673208 0.74 CES2 (0.55) CES2CES1L3MBTL1SMN1; SMN2HPGD
SCHEMBL21517648 0.74 CES2 (1.00) CES2CES1L3MBTL1SMN1; SMN2HPGD
SCHEMBL6206612 0.71 CES1 (0.48) CES2CES1TSHRALDH1A1
SCHEMBL6666603 0.71 CES1 (0.48) CES2CES1L3MBTL1SMN1; SMN2HPGD
SCHEMBL16796028 0.71 CYP2C19 (0.46) CES2CES1L3MBTL1HPGDCYP2C19
Benzoic Acid SCHEMBL30453578 0.71 TSHR (0.56) CES2CES1L3MBTL1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532128-A1 INHIBITORS OF HCV NS5B POLYMERASE Pharmacia & Upjohn Company LLC (US) 2005-05-25 EP disclosed
WO-2004002977-A1 INHIBITORS OF HCV NS5B POLYMERASE PHARMACIA & UPJOHN COMPANY LLC (US) 2004-01-08 WO disclosed